Literature DB >> 14706290

The calmodulin binding region of the skeletal ryanodine receptor acts as a self-modulatory domain.

Xinsheng Zhu1, Jyothi Ghanta, Jeffrey W Walker, Paul D Allen, Héctor H Valdivia.   

Abstract

A synthetic peptide (CaMBP) matching amino acids 3614-3643 of the skeletal ryanodine receptor (RyR1) binds to both Ca2+-free calmodulin (CaM) and Ca2+-bound CaM with nanomolar affinity [J. Biol. Chem. 276 (2001) 2069]. We report here that CaMBP increases [3H]ryanodine binding to RyR1 in a dose- and Ca2+-dependent manner; it also induces Ca2+ release from SR vesicles, and increases open probability (P(o)) of single RyR channels reconstituted in planar lipid bilayers. Further, CaMBP removes CaM associated with SR vesicles and increases [3H]ryanodine binding to purified RyR1, suggesting that its mechanism of action is two-fold: it removes endogenous inhibitors and also interacts directly with complementary regions in RyR1. Remarkably, the N-terminus of CaMBP activates RyRs while the C-terminus of CaMBP inhibits RyR activity, suggesting the presence of two discrete functional subdomains within this region. A ryr1 mutant lacking this region, RyR1-Delta3614-3643, was constructed and expressed in dyspedic myoblasts (RyR1-knockout). The depolarization-, caffeine- and 4-chloro-m-cresol (4-CmC)-induced Ca2+ transients in these cells were dramatically reduced compared with cells expressing wild type RyR1. Deletion of the 3614-3643 region also resulted in profound changes in unitary conductance and channel gating. We thus propose that the RyR1 3614-3643 region acts not only as the CaM binding site, but also as an important modulatory domain for RyR1 function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14706290     DOI: 10.1016/j.ceca.2003.09.002

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  11 in total

1.  Subtype identification and functional characterization of ryanodine receptors in rat cerebral artery myocytes.

Authors:  Thirumalini Vaithianathan; Damodaran Narayanan; Maria T Asuncion-Chin; Loice H Jeyakumar; Jianxi Liu; Sidney Fleischer; Jonathan H Jaggar; Alejandro M Dopico
Journal:  Am J Physiol Cell Physiol       Date:  2010-05-05       Impact factor: 4.249

2.  Aberrant interaction of calmodulin with the ryanodine receptor develops hypertrophy in the neonatal cardiomyocyte.

Authors:  Jaya P Gangopadhyay; Noriaki Ikemoto
Journal:  Biochem J       Date:  2011-09-01       Impact factor: 3.857

3.  Role of the Met3534-Ala4271 region of the ryanodine receptor in the regulation of Ca2+ release induced by calmodulin binding domain peptide.

Authors:  Jaya Pal Gangopadhyay; Noriaki Ikemoto
Journal:  Biophys J       Date:  2005-12-30       Impact factor: 4.033

4.  A Ca2+-binding domain in RyR1 that interacts with the calmodulin binding site and modulates channel activity.

Authors:  Liangwen Xiong; Jia-Zheng Zhang; Rong He; Susan L Hamilton
Journal:  Biophys J       Date:  2005-10-14       Impact factor: 4.033

5.  Phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) potentiates cardiac contractility via activation of the ryanodine receptor.

Authors:  Chad D Touchberry; Ian K Bales; Jessica K Stone; Travis J Rohrberg; Nikhil K Parelkar; Tien Nguyen; Oscar Fuentes; Xia Liu; Cheng-Kui Qu; Jon J Andresen; Héctor H Valdivia; Marco Brotto; Michael J Wacker
Journal:  J Biol Chem       Date:  2010-10-14       Impact factor: 5.157

6.  Two potential calmodulin-binding sequences in the ryanodine receptor contribute to a mobile, intra-subunit calmodulin-binding domain.

Authors:  Xiaojun Huang; Ying Liu; Ruiwu Wang; Xiaowei Zhong; Yingjie Liu; Andrea Koop; S R Wayne Chen; Terence Wagenknecht; Zheng Liu
Journal:  J Cell Sci       Date:  2013-07-18       Impact factor: 5.285

7.  Deficiency of MIP/MTMR14 phosphatase induces a muscle disorder by disrupting Ca(2+) homeostasis.

Authors:  Jinhua Shen; Wen-Mei Yu; Marco Brotto; Joseph A Scherman; Caiying Guo; Christopher Stoddard; Thomas M Nosek; Héctor H Valdivia; Cheng-Kui Qu
Journal:  Nat Cell Biol       Date:  2009-05-24       Impact factor: 28.824

8.  Activation of IP3 receptors requires an endogenous 1-8-14 calmodulin-binding motif.

Authors:  Yi Sun; Ana M Rossi; Taufiq Rahman; Colin W Taylor
Journal:  Biochem J       Date:  2013-01-01       Impact factor: 3.857

Review 9.  Malignant hyperthermia: a review.

Authors:  Henry Rosenberg; Neil Pollock; Anja Schiemann; Terasa Bulger; Kathryn Stowell
Journal:  Orphanet J Rare Dis       Date:  2015-08-04       Impact factor: 4.123

10.  Loss of S100A1 expression leads to Ca2+ release potentiation in mutant mice with disrupted CaM and S100A1 binding to CaMBD2 of RyR1.

Authors:  Erick O Hernández-Ochoa; Zephan Melville; Camilo Vanegas; Kristen M Varney; Paul T Wilder; Werner Melzer; David J Weber; Martin F Schneider
Journal:  Physiol Rep       Date:  2018-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.